Indocin is a prescription-strength nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute gout flares, bursitis, and tendonitis. Available in immediate- and extended-release capsules, oral suspension, and rectal suppositories, Indocin helps reduce swelling and improve mobility. Because it carries important cardiovascular, gastrointestinal, kidney, and liver safety risks, it should be used at the lowest effective dose for the shortest duration that controls symptoms. Discuss your medical history and current medications with a licensed clinician before starting indomethacin.
Indocin is an NSAID that reduces prostaglandin production, easing pain, swelling, and stiffness. Clinicians commonly prescribe indomethacin for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute gouty arthritis, and inflammatory soft-tissue conditions such as bursitis and tendonitis. Many patients notice improved joint function and faster resolution of inflammatory flares compared with over-the-counter NSAIDs, especially during acute gout attacks.
In hospital settings, specialized forms of indomethacin may be used under strict supervision for unique indications (for example, ductus arteriosus management in premature infants), but this is not a self-care use. For outpatient adults, Indocin’s role is targeted relief of musculoskeletal inflammatory pain when benefits outweigh risks.
Use the lowest effective dose for the shortest possible time. Typical adult dosing varies by condition and formulation. For osteoarthritis, rheumatoid arthritis, or ankylosing spondylitis, clinicians often begin with 25 mg two to three times daily and adjust based on response, with a common maximum daily dose of 150–200 mg. Extended-release capsules (e.g., 75 mg) may be taken once or twice daily, offering steadier symptom control for some patients.
For acute gout flares, an initial regimen such as 50 mg three times daily is frequently used for rapid control, then tapered as symptoms subside, not exceeding the recommended maximum daily amount. For bursitis and tendonitis, short courses totaling 75–150 mg per day in divided doses are typical. Rectal suppositories (often 50 mg) can be considered when oral dosing is not feasible, but are not suitable for patients with proctitis or rectal bleeding.
Swallow capsules whole with food or milk to reduce stomach upset; do not crush or chew extended-release forms. Food may lessen dyspepsia but does not eliminate the risk of serious bleeding. Avoid alcohol during therapy, which heightens gastrointestinal and liver risks. Older adults and those with kidney, liver, or cardiovascular disease often require lower doses and closer monitoring. Never exceed the dose your clinician recommends.
Indomethacin carries boxed warnings for increased risks of serious cardiovascular events (heart attack, stroke), especially with long-term use, higher doses, or in patients with established cardiovascular disease. It is also associated with gastrointestinal ulcers, bleeding, and perforation, which can occur without warning and at any time. These risks are higher in older adults, those with prior ulcers or GI bleeding, and individuals using alcohol, corticosteroids, anticoagulants, or other NSAIDs.
Indocin may elevate blood pressure, cause fluid retention and edema, and worsen heart failure. Kidney effects include acute kidney injury; risk rises with dehydration, diuretics, ACE inhibitors/ARBs, and preexisting renal disease. Liver enzyme elevations can occur; rare severe hepatic injury has been reported. Serious skin reactions (including Stevens-Johnson syndrome and toxic epidermal necrolysis) and anaphylactoid reactions may develop, particularly in aspirin-sensitive asthma.
Pregnancy considerations are critical: avoid use at 20 weeks’ gestation and later due to risk of fetal kidney dysfunction and oligohydramnios; in the third trimester, indomethacin can cause premature closure of the ductus arteriosus. Discuss breastfeeding with your clinician. Indomethacin may impair fertility in some individuals. Dizziness, drowsiness, and blurred vision can occur—use caution when driving or operating machinery. For long-term therapy, clinicians may monitor blood pressure, kidney function, liver enzymes, blood counts, and signs of GI bleeding.
Do not use indomethacin if you have a history of hypersensitivity to indomethacin or other NSAIDs, or if you’ve experienced asthma, urticaria, or allergic-type reactions after aspirin or NSAIDs. Indomethacin is contraindicated in the setting of coronary artery bypass graft (CABG) surgery. Avoid use with active gastrointestinal bleeding or peptic ulcer disease. Advanced kidney disease, significant liver impairment, and uncontrolled heart failure warrant avoidance unless the potential benefit clearly outweighs risks under close supervision. Rectal suppositories are contraindicated in proctitis or recent rectal bleeding.
Common side effects include stomach pain, nausea, heartburn, constipation or diarrhea, gas, dizziness, headache, fatigue, ringing in the ears, and mild swelling. Taking doses with food may ease dyspepsia, though serious GI events can still occur. Some people experience mood changes, nervousness, or trouble sleeping.
Serious adverse effects require urgent medical care: chest pain, shortness of breath, sudden weakness or trouble speaking (possible stroke), black or bloody stools, vomiting blood or coffee-ground material (GI bleeding), severe stomach pain, jaundice or dark urine (liver injury), marked decrease in urination or swelling of legs (kidney injury), easy bruising or unusual bleeding, severe headache or confusion, fainting or seizures, and blistering or peeling rash. Severe allergic reactions may present with wheezing, facial or throat swelling, hives, or sudden difficulty breathing—call emergency services immediately.
Indomethacin can interact with many medications. Combining with anticoagulants (e.g., warfarin), antiplatelets (e.g., clopidogrel), or SSRIs/SNRIs increases bleeding risk. Using other NSAIDs or high-dose aspirin heightens GI toxicity; low-dose aspirin for heart protection may have reduced antiplatelet efficacy when taken with some NSAIDs—ask your clinician about timing and alternatives. Corticosteroids also increase ulcer/bleeding risk.
ACE inhibitors, ARBs, beta-blockers, and diuretics may be less effective with NSAIDs; together they can raise kidney injury risk, especially in dehydrated or older adults. Indomethacin can increase lithium levels (toxicity risk) and methotrexate exposure; cyclosporine co-use raises nephrotoxicity risk. Probenecid may elevate indomethacin concentrations. Alcohol and tobacco further raise GI risks. Certain chemotherapy agents (e.g., pemetrexed) and digoxin can interact; bile-acid sequestrants may alter absorption. Provide a complete medication and supplement list—including OTC pain relievers and herbal products—to your clinician or pharmacist before starting Indocin.
If you miss a dose, take it when you remember unless it is close to the time for your next scheduled dose. In that case, skip the missed dose and resume your regular schedule. Do not double up to “catch up,” as this increases adverse-effect risks. For short courses during acute flares, staying on the prescribed schedule improves symptom control; consult your clinician if you miss multiple doses.
Signs of overdose may include severe nausea or vomiting, intense abdominal pain, drowsiness, confusion, dizziness, headache, ringing in the ears, blurred vision, fainting, seizures, difficulty breathing, bloody or black stools, and markedly reduced urination. Overdose can lead to dangerous bleeding, kidney failure, or cardiovascular events. Seek emergency medical attention immediately or contact Poison Control (in the U.S., 1-800-222-1222) for guidance. Do not attempt to self-treat an overdose.
Store indomethacin at room temperature, ideally 68–77°F (20–25°C), in a dry place away from heat and direct light. Keep in the original, tightly closed container and out of reach of children and pets. Do not store in the bathroom. Protect liquid formulations from freezing. Safely discard expired or unused medication according to local guidelines or pharmacy take-back programs.
In the United States, indomethacin is a prescription medication due to its potency and safety considerations. Federal and state laws require appropriate clinical oversight before dispensing. Avoid sources that claim to sell prescription-strength NSAIDs without safeguards, as this can endanger your health and may violate regulations.
HealthSouth Hospital of Altamonte Springs offers a legal and structured solution to buy Indocin without prescription in the traditional sense by incorporating clinician oversight within its service. Instead of asking you to provide an external paper prescription, a licensed provider reviews your health history, checks for contraindications and drug interactions, and authorizes therapy when appropriate. This preserves medical screening and documentation while offering convenient access. Eligibility, quantity limits, and safety protocols apply; not everyone will qualify, and ongoing medical follow-up may be recommended. This compliant model helps balance accessibility with patient safety and regulatory requirements, ensuring indomethacin is used responsibly.
Indocin is a nonsteroidal anti-inflammatory drug (NSAID) used to reduce pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, bursitis, tendinitis, and acute gout flares; in hospitals, it may be used for patent ductus arteriosus in newborns under specialist care.
It inhibits COX-1 and COX-2 enzymes, lowering prostaglandin production that drives inflammation, pain, and fever; this mechanism also explains many side effects, especially in the stomach, kidneys, and cardiovascular system.
Avoid if you have NSAID/aspirin allergy, a history of asthma or hives with NSAIDs, active GI bleeding or ulcers, severe heart failure, recent heart attack or stroke risks requiring caution, advanced kidney disease, or after coronary bypass surgery; it is contraindicated in the third trimester of pregnancy.
Nausea, heartburn, abdominal pain, headache, dizziness, drowsiness, fluid retention, and elevated blood pressure are common; less often it can cause rash, ringing in the ears, or mood changes.
Seek urgent care for black or bloody stools, vomiting blood, severe stomach pain, chest pain, shortness of breath, sudden weakness or slurred speech, marked swelling or weight gain, little or no urine, yellowing of skin/eyes, or severe skin reactions; NSAIDs carry boxed warnings for heart attack/stroke and GI bleeding/perforation.
Typical adult dosing starts at 25 mg two or three times daily with food or milk, adjusted to effect; some patients use 50 mg two or three times daily or a 75 mg extended-release capsule once or twice daily, with a common max of 200 mg/day—follow your prescriber’s plan and use the lowest effective dose for the shortest time.
Yes; a common regimen is 50 mg three times daily at flare onset for a few days, then taper as pain improves, but schedules vary—start early in the attack, do not combine with other NSAIDs, and consult your clinician about duration and gastroprotection if you’re high risk.
Pain relief often begins within 30–60 minutes after a dose, with fuller anti-inflammatory benefit developing over several days of consistent use.
Take with food or milk to reduce stomach upset, though it doesn’t eliminate ulcer risk; avoid or minimize alcohol to lower GI bleeding risk; caffeine is generally acceptable but may worsen stomach irritation or jitters in some people.
Major interactions include anticoagulants (warfarin), antiplatelets (aspirin, clopidogrel), SSRIs/SNRIs, corticosteroids (bleeding risk), ACE inhibitors/ARBs/diuretics (kidney effects, blood pressure), lithium and methotrexate (toxicity), cyclosporine, and other NSAIDs; always review your full medication list with a clinician.
Avoid in the third trimester due to risk of premature ductus arteriosus closure; earlier pregnancy use should be limited and closely supervised; small amounts pass into breast milk—short-term use may be acceptable with monitoring, but discuss with your obstetrician/pediatrician.
They can, but older adults face higher risks of GI bleeding, kidney problems, and cardiovascular events; start low, monitor closely, consider proton-pump inhibitor protection, and reassess regularly.
Combining increases GI bleeding risk and may interfere with aspirin’s antiplatelet effect if timed improperly; if your clinician approves, they may recommend specific timing and gastroprotection—never combine NSAIDs without guidance.
If you miss a dose, take it when remembered unless it’s close to the next; never double up; in overdose (severe drowsiness, vomiting, confusion, stomach bleeding, seizures), call emergency services or poison control immediately.
Other NSAIDs (e.g., naproxen, ibuprofen, meloxicam, celecoxib), colchicine for gout, corticosteroids, topical diclofenac, physical therapy, and non-drug strategies may be options—your clinician can tailor a plan based on risks and goals.
Yes; NSAIDs can increase blood pressure, cause fluid retention, and reduce kidney blood flow, especially with dehydration, diuretics, ACE inhibitors/ARBs, or preexisting kidney disease; monitor blood pressure and kidney function as advised.
For intermittent pain or gout flares, as-needed use is common; for chronic arthritis, scheduled dosing may work better initially—follow your prescriber’s instructions and reassess response and risks regularly.
Keep capsules or suspension at room temperature in a dry place, away from heat and moisture, and out of reach of children; do not use past the expiration date.
Prostaglandin inhibition can impair ovulation and may reduce fertility while taking it; this effect is usually reversible after stopping.
Indocin is generally more potent anti-inflammatory than ibuprofen and is often favored for gout flares, but it carries higher rates of CNS side effects (headache, dizziness) and GI irritation; ibuprofen tends to be better tolerated for everyday pain at OTC or prescription doses.
Naproxen has a longer half-life and provides 8–12 hours of relief per dose, often enabling twice-daily dosing; Indocin has a shorter half-life (except in extended-release form), which may require more frequent dosing but can act quickly for flares.
Both are effective; diclofenac (oral) offers strong anti-inflammatory effects but is linked to higher cardiovascular risk than some NSAIDs; Indocin has more CNS side effects and GI risk; for localized osteoarthritis, topical diclofenac often balances benefit and safety better than either oral option.
Meloxicam is COX-2–preferential and tends to have a lower rate of GI side effects at standard doses, with convenient once-daily dosing; Indocin may work faster or stronger in select inflammatory conditions but with a higher likelihood of GI and neurologic adverse effects.
Celecoxib (a COX-2 selective NSAID) generally causes fewer GI ulcers and bleeds than nonselective NSAIDs like Indocin, especially when not combined with aspirin; cardiovascular risk varies by patient—naproxen may be neutral, diclofenac higher, celecoxib moderate, and individual risk factors should guide the choice.
Ketorolac is a very potent NSAID for short-term, acute pain (often injectable) and is limited to a maximum of five days due to high GI/renal risk; Indocin is suited to inflammatory arthritis and gout flares for limited courses or carefully monitored chronic use.
Both increase bleeding risk when combined; low-dose aspirin for heart protection may be used with an NSAID if clinically necessary, but timing and gastroprotection are important—many clinicians prefer naproxen with aspirin over indomethacin to reduce interaction concerns.
They have similar anti-inflammatory efficacy; sulindac is a prodrug that some clinicians favor in patients with certain renal concerns, though evidence is mixed; Indocin tends to cause more headache/dizziness, while both share GI and CV risks typical of NSAIDs.
Etodolac is relatively COX-2–preferential and may be easier on the stomach at standard doses, with once- or twice-daily regimens; Indocin may provide robust anti-inflammatory action but often at the cost of more CNS and GI side effects.
Piroxicam has a very long half-life, allowing once-daily dosing but with a higher risk of GI ulceration and skin reactions; Indocin requires more frequent dosing (unless extended-release) and carries more CNS effects—both need careful risk assessment.
For localized osteoarthritis of the knee or hand, topical diclofenac provides meaningful pain relief with far less systemic exposure and GI risk than oral indomethacin, making topical therapy a strong first-line option for many patients.
Both are effective for acute gout; indomethacin has historical use and rapid onset, while naproxen offers longer dosing intervals and may be better tolerated; choice depends on individual risk factors, previous response, and clinician preference.
Ibuprofen is typically preferred for tension headaches and migraines due to better tolerability and OTC availability; Indocin can trigger or worsen headache in some people and is not a first-line headache medication.
Celecoxib with a proton-pump inhibitor generally offers lower recurrent GI bleeding risk than nonselective NSAIDs like indomethacin; individual cardiovascular risk and aspirin use still need to be factored into the decision.